Nitric oxide inhibits neuroendocrine CaV1 L-channel gating via cGMP-dependent protein kinase in cell-attached patches of bovine chromaffin cells

Journal of Physiology

Volumn 541, Issue 2, 2002, Pages 351-366

  Carabelli, Valentina ^a   D'Ascenzo, Marcello ^b   Carbone, Emilio ^a   Grassi, Claudio ^b  

^a INFM   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; 8 BROMO CYCLIC GMP; AUTORECEPTOR; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CATECHOLAMINE; CYCLIC AMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE INHIBITOR; KT 5823; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUROTRANSMITTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; SCAVENGER;

ADRENAL GLAND; ANIMAL CELL; ARTICLE; CATECHOLAMINE RELEASE; CELL ADHESION; CELL MEMBRANE CONDUCTANCE; CHANNEL GATING; CHROMAFFIN CELL; CONTROLLED STUDY; MEMBRANE CURRENT; NEUROENDOCRINE SYSTEM; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; RECEPTOR UPREGULATION; AUTOCRINE EFFECT; AUTOREGULATION; BOVINE; CELL ATTACHED PATCH CLAMP; MEAN CHANNEL OPEN TIME; MEMBRANE CONDUCTANCE; SIGNAL TRANSDUCTION; SINGLE CHANNEL PATCH CLAMP; UPREGULATION;

ANIMALS; BENZOATES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CATTLE; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; GUANYLATE CYCLASE; HOMEOSTASIS; IMIDAZOLES; ION CHANNEL GATING; NEUROSECRETORY SYSTEMS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OOCYTES; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE C; SIGNAL TRANSDUCTION; XENOPUS LAEVIS;

EID: 0036623820     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2002.017749     Document Type: Article

References (64)

1. AIZENMAN, E., BRIMECOMBE, J. C., POTTHOFF, W. K. & ROSENBERG, P. A. (1998). Why is the role of nitric oxide in NMDA receptor function and dysfunction so controversial? Progress in Brain Research 118, 53-71.
2. AZZENA, G. B., FERRARESI A., FILIPPI, G. M., GRASSI, C., MANNI, E. & TROIANI, D. (2000). Propriocettive afferents from extraocular muscles and oculomotor control. Pflügers Archiv 439, R263.
3. BARRY, P. H. & LYNCH, J. W. (1991). Liquid junction potentials and small cell effects in patch-clamp analysis. Journal of Membrane Biology 121, 101-117.
4. BATES, J. N., BAKER, M. T., GUERRA, R. & HARRISON, D. G. (1991). Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochemical Pharmacology 42, S157-165.
5. BELL, D. C., BUTCHER, A. J., BERROW, N. S., PAGE, K. M., BRUST, P. F., NESTEROVA, A., STAUDERMAN, K. A., SEABROOK, G. R., NÜRNBERG, B. & DOLPHIN, A. C. (2001). Biophysical properties, pharmacology, and modulation of human, neuronal L-Type (α1D, CaV1.3) voltage-dependent calcium currents. Journal of Neurophysiology 85, 816-827.
6. BOLOTINA, V. M., NAJIBI, S., PALACINO, J. J., PAGANO, P. J. & COHEN, R. A. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368, 850-853.
7. BREDT, D. S. & SNYDER, S. H. (1990). Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proceedings of the National Academy of Sciences of the USA 87, 682-685.
8. BURKHARDT, M., GLAZOVA, M., GAMBARYAN, S., VOLLKOMMER, T., BUTT, E., BADER, B., HEERMEIR, K., LINCOLN, T. M., WALTER, U. & PALMETSHOFER, A. (2000). KT5823 inhibits cGPM-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. Journal of Biological Chemistry 275, 33536-33541.
9. 2+ channel modulation in bovine chromaffin cells. Neuron 20, 1255-1268.
10. 2+ channels in bovine chromaffin cells. Journal of Physiology 532, 73-90.
11. 2+ channel kinetics by receptor agonists in IMR32 cells. Biophysical Journal 70, 2144-2154.
12. CARBONE, E., CARABELLI, V., BALDELLI, P., CESETTI, T., HERNÁNDEZ-GUIJO, J. M. & GIUSTA, L. (2001). G-protein- and cAMP-dependent L-channel gating modulation: a manyfold system to control calcium entry in neurosecretory cells. Pflügers Archiv 442, 801-813.
13. 2+ current inhibition in rat sympathetic neurons. Journal of Physiology 482, 521-531.
14. 2+ channel currents through protein phosphorylation in rat pinealocytes. Journal of Neuroscience 15, 3104-3109.
15. CHOI, Y. B., TENNETI, L., LE, D. A., ORTIZ, J., BAI, G., CHEN, H. S. & LIPTON, S. A. (2000). Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nature Neuroscience 3, 15-21.
16. CLEMENTI, E., RICCIO, M., SCIORATI, C., NISTICÒ, G. & MELDOLESI, J. (1996). Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation. Journal of Biological Chemistry 271, 17739-17745.
17. COLQUHOUN, D. & HAWKES, A. G. (1981). On the stochastic properties of single ion channels. Proceedings of the Royal Society B 211, 205-235.
18. DOLPHIN, A. C. (1998). Mechanisms of modulation of voltage-dependent calcium channels by G proteins. Journal of Physiology 506, 3-11.
19. DUN, N. J., DUN, S. L., WU, S. Y. & FORSTERMANN, U. (1993). Nitric oxide synthase immunoreactivity in rat superior cervical ganglia and adrenal glands. Neuroscience Letters 158, 51-54.
20. GALLO, M. P., GHIGO, D., BOSIA, A., ALLOATTI, G., COSTAMAGNA, C., PENNA, C. & LEVI, R. C. (1998). Modulation of guinea-pig cardiac L-type calcium current by nitric oxide synthase inhibitors. Journal of Physiology 506, 639-654.
21. 2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 19, 185-196.
22. GARCÍA, A. G., SALA, F., REIG, J. A., VINIEGRA, S., FRÍAS, J., FONTERIZ, R.I. & GANDÍA, L. (1984). Dihydropyridine BAY-K-8644 activates chromaffin cell calcium channels. Nature 309, 69-71.
23. GARTHWAITE, J., SOUTHAM, E., BOULTON, C. L., NIELSEN, E.B., SCHMIDT, K. & MAYER, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H- [ 1,2,4]oxadiazolo [4,3-a] quinoxalin- 1 -one. Molecular Pharmacology 48, 148-188.
24. 2+ channel inhibition induced by nitric oxide in rat insulinoma RINm5F cells. Pflügers Archiv 437, 241-247.
25. GRASSI, C., SANTARELLI, R., NISTICÒ, S., BAGETTA, G. & AZZENA, G. B. (1995). Possible modulation of auditory middle latency responses by nitric oxide in the inferior colliculus of anaesthetized rats. Neuroscience Letters 196, 213-217.
26. GRIDER, J. R. (1993). Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. American Journal of Physiology 264, G334-340.
27. HALEY, J. E., DICKENSON, A.H. & SCHACHTER, M. (1992). Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 31, 251-258.
28. HAMILL, O. P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Archiv 391, 85-100.
29. HAN, X., SHIMONI, Y. & GILES, W. R. (1994). An obligatory role for nitric oxide in autonomic control of mammalian heart rate. Journal of Physiology 476, 309-314.
30. HESS, P., LANSMAN, J. B. & TSIEN, R. W. (1984). Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 311, 538-544.
31. HIROOKA, K., KOURENNYI, D. E. & BARNES, S. (2000). Calcium channel activation facilitated by nitric oxide in retinal ganglion cells. Journal of Neurophysiology 83, 198-206.
32. 2+ channels by S-nitrosothiol nitric oxide donors. Circulation Research 81, 742-752.
33. IGNARRO, L. J., BUGA, G. M., WOOD, K. S., BYRNS, R. E. & CHAUDHURI, G. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the USA 84, 9265-9269.
34. JIANG, L. H., GAWLER, D. J., HODSON, N., MILLIGAN, C. J., PEARSON, H.A., PORTER, V. & WRAY, D. (2000). Regulation of cloned cardiac L-type calcium channels by cGMP-dependent protein kinase. Journal of Biological Chemistry 275, 6135-6143.
35. KAVALALI, E. T., HWANG, K.S. & PLUMMER, M. R. (1997). cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons. Journal of Neuroscience 17, 5334-5348.
36. KIM, S.J., LIM, W. & KIM, J. (1995). Contribution of L- and N-type calcium currents to exocytosis in rat adrenal medullary chromaffin cells. Brain Research 675, 289-296.
37. KIM, S.J., SONG, S.K. & KIM, J. (2000). Inhibitory effect of nitric oxide on voltage-dependent calcium currents in rat dorsal root ganglion cells. Biochemical and Biophysical Research Communications 271, 509-514.
38. KURENNY, D. E, MOROZ, L. L., TURNER, R.W., SHARKEY, K.A. & BARNES, S. (1994). Modulation of ion channels in rod photoreceptors by nitric oxide. Neuron 13, 315-324.
39. 2+ channel activity in excised patches of PTX-treated granule cells of the cerebellum. Journal of Neuroscience 15, 6014-6022.
40. Ca) channels in myocytes of the guinea-pig taenia caeci. Journal of Physiology 525, 363-376.
41. LI, Z., CHAPLEAU, M. W., BATES, J. N., BIELEFELDT, K., LEE, H.-C. & ABBOUD, M. (1998). Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron 20, 1039-1049.
42. 2+ signals and secretion in chromaffin cell subtypes. American Journal of Physiology 2727, C476-484.
43. 2+ channels dominate the control of secretion in bovine chromaffin cells. FEBS Letters 349, 331-337.
44. MACHADO, J. D., SEGURA, F., BRIOSO, M. A. & BORGES, R. (2000). Nitric oxide modulates a late step of exocytosis. Journal of Biological Chemistry 275, 20274-20279.
45. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. Journal of Biological Chemistry 268, 26286-26295.
46. MORO, M. A., MICHELENA, P., SANCHEZ-GARCÍA, P., PALMER, R., MONCADA, S. & GARCÍA, A. G. (1993). Activation of adrenal medullary L-arginine: nitric oxide pathway by stimuli which induce the release of catecholamines. European Journal of Pharmacology 246, 213-218.
47. NAGAYAMA, T., HOSOKAWA A., YOSHIDA, M., SUZUKI-KUSABA, M., HISA, H., KIMURA, T. & SATOH, S. (1998). Role of nitric oxide in adrenal catecholamine secretion in anesthetized dogs. American Journal of Physiology 275, R1075-1081.
48. NAGAYAMA, T., MATSUMOTO, T., KUWAKUBO, F., FUKUSHIMA, Y., YOSHIDA, M., SUZUKI-KUSABA, M., HISA, H., KIMURA, T. & SATOH, S. (1999). Role of calcium channels in catecholamine secretion in the rat adrenal gland. Journal of Physiology 520, 503-512.
49. NEHER, E. (1992). Correction for liquid junction potentials in patch clamp experiments. Methods in Enzymology 207, 123-131.
50. OSET-GASQUE, M. J., PARRAMON, M., HORTELANO, S., BOSCA, L. & GONZALES, M. P. (1994). Nitric oxide implication in the control of neurosecretion by chromaffin cells. Journal of Neurochemistry 63, 1693-1700.
51. O'SULLIVAN, A.J. & BURGOYNE, R. D. (1990). Cyclic GMP regulates nicotine-induced secretion from cultured bovine adrenal chromaffin cells: effects of 8-bromo-cyclic GMP, atrial natriuretic peptide, and nitroprusside (nitric oxide). Journal of Neurochemistry 54, 1805-1808.
52. PALMER, R.M.J., FERRIGE, A. G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium- derived relaxing factor. Nature 327, 524-526.
53. RAUCH, M., SCHMID, H. A., DEVENTE, J. & SIMON, E. (1997). Electrophysiological and immunocytochemical evidence for a cGMP-mediated inhibition of subfornical organ neurons by nitric oxide. Journal of Neuroscience 17, 363-371.
54. 2+ influx by 8-bromo-guanosine-3′:5′-monophosphate, cyclic (8-Br-cGMP) in bovine adrenal chromaffin cells. Neuroscience Letters 180, 269-272.
55. RODRIGUEZ-PASCUAL, F., MIRAS-PORTUGAL, M.T. & TORRES, M. (1996). Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase. Molecular Pharmacology 49, 1058-1070.
56. SHUMAN, E.M. & MADISON, D. V. (1994). Nitric oxide and synaptic function. Annual Review of Neuroscience 17, 153-183.
57. SCHWARZ, P. M., RODRIGUEZ-PASCUAL, F., KOESLING, D., TORRES, M. & FÖRSTERMANN, U. (1998). Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells. Neuroscience 82, 255-265.
58. STOYANOVSKY, D., MURPHY, T., ANNO, P.R., KIM, Y.-M. & SALAMA, G. (1997). Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21, 19-29.
59. 2+ current in glomus cells of the rabbit carotid body via a cGMP-independent mechanism. Journal of Neurophysiology 81, 1449-1457.
60. 2+ availability in basilar artery smooth muscle cells. Pflügers Archiv 433, 304-311.
61. TOHSE, N. & SPERELAKIS, N. (1991). cGMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circulation Research 69, 325-331.
62. TORRES, M., CEBALLOS, G. & RUBIO, R. (1994). Possible role of nitric oxide in catecholamine secretion by chromaffin cells in the presence and absence of cultured endothelial cells. Journal of Neurochemistry 63, 988-996.
63. WAHLER, G. M. & DOLLINGER, S. J. (1995). Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase. American Journal of Physiology 426, C45-54.
64. 2+ mobilization and increases secretion of incorporated 5-hydroxytryptamine in rat pancreatic β-cells. FEBS Letters 371, 1981-1992.